Iceni Pharmaceuticals

BigDNA Pharmaceuticals focuses on developing innovative cancer therapies by repurposing and reformulating existing drugs for new medical indications. This approach significantly reduces the cost and risk associated with the drug development process, as these drugs have already undergone extensive clinical trials and have well-established safety profiles. The company primarily serves patients in need of new cancer treatments, as well as investors and licensees looking for de-risked investment opportunities. Operating in the pharmaceutical and biotechnology market, BigDNA employs a business model centered around drug development and commercialization. Revenue is generated through the licensing of their reformulated drugs and partnerships with other pharmaceutical companies.

Keywords: cancer therapies, drug repurposing, drug reformulation, clinical trials, safety profiles, cost reduction, risk reduction, pharmaceutical market, biotechnology, investment opportunities.